rs61752971

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 1P and 9B. PP3BP6BS1BS2

The NM_000276.4(OCRL):​c.439+3A>G variant causes a splice region, intron change. The variant allele was found at a frequency of 0.00334 in 1,136,037 control chromosomes in the GnomAD database, including 2 homozygotes. There are 1,075 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0025 ( 0 hom., 60 hem., cov: 23)
Exomes 𝑓: 0.0034 ( 2 hom. 1015 hem. )

Consequence

OCRL
NM_000276.4 splice_region, intron

Scores

2
Splicing: ADA: 0.9996
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:13

Conservation

PhyloP100: 5.32

Publications

3 publications found
Variant links:
Genes affected
OCRL (HGNC:8108): (OCRL inositol polyphosphate-5-phosphatase) This gene encodes an inositol polyphosphate 5-phosphatase. This protein is involved in regulating membrane trafficking and is located in numerous subcellular locations including the trans-Golgi network, clathrin-coated vesicles and, endosomes and the plasma membrane. This protein may also play a role in primary cilium formation. Mutations in this gene cause oculocerebrorenal syndrome of Lowe and also Dent disease. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
OCRL Gene-Disease associations (from GenCC):
  • Dent disease type 2
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Ambry Genetics, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae)
  • oculocerebrorenal syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Laboratory for Molecular Medicine, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

PP3
Splicing predictors support a deleterious effect. Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF, max_spliceai. No scorers claiming Uncertain. No scorers claiming Benign.
BP6
Variant X-129557953-A-G is Benign according to our data. Variant chrX-129557953-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 92725.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00245 (275/112228) while in subpopulation NFE AF = 0.00372 (198/53228). AF 95% confidence interval is 0.00329. There are 0 homozygotes in GnomAd4. There are 60 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 60 XL gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000276.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
OCRL
NM_000276.4
MANE Select
c.439+3A>G
splice_region intron
N/ANP_000267.2
OCRL
NM_001318784.2
c.442+3A>G
splice_region intron
N/ANP_001305713.1
OCRL
NM_001587.4
c.439+3A>G
splice_region intron
N/ANP_001578.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
OCRL
ENST00000371113.9
TSL:1 MANE Select
c.439+3A>G
splice_region intron
N/AENSP00000360154.4Q01968-1
OCRL
ENST00000357121.5
TSL:1
c.439+3A>G
splice_region intron
N/AENSP00000349635.5Q01968-2
OCRL
ENST00000949289.1
c.436+3A>G
splice_region intron
N/AENSP00000619348.1

Frequencies

GnomAD3 genomes
AF:
0.00245
AC:
275
AN:
112177
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.000583
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00188
Gnomad ASJ
AF:
0.00341
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000369
Gnomad FIN
AF:
0.00378
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00372
Gnomad OTH
AF:
0.00396
GnomAD2 exomes
AF:
0.00240
AC:
440
AN:
183361
AF XY:
0.00265
show subpopulations
Gnomad AFR exome
AF:
0.000228
Gnomad AMR exome
AF:
0.00106
Gnomad ASJ exome
AF:
0.00214
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00375
Gnomad NFE exome
AF:
0.00367
Gnomad OTH exome
AF:
0.00309
GnomAD4 exome
AF:
0.00344
AC:
3518
AN:
1023809
Hom.:
2
Cov.:
23
AF XY:
0.00337
AC XY:
1015
AN XY:
301535
show subpopulations
African (AFR)
AF:
0.000440
AC:
11
AN:
25024
American (AMR)
AF:
0.00102
AC:
36
AN:
35134
Ashkenazi Jewish (ASJ)
AF:
0.00201
AC:
38
AN:
18941
East Asian (EAS)
AF:
0.00
AC:
0
AN:
29935
South Asian (SAS)
AF:
0.00126
AC:
66
AN:
52516
European-Finnish (FIN)
AF:
0.00444
AC:
180
AN:
40506
Middle Eastern (MID)
AF:
0.00151
AC:
6
AN:
3961
European-Non Finnish (NFE)
AF:
0.00397
AC:
3076
AN:
774063
Other (OTH)
AF:
0.00240
AC:
105
AN:
43729
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
103
206
309
412
515
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
120
240
360
480
600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00245
AC:
275
AN:
112228
Hom.:
0
Cov.:
23
AF XY:
0.00174
AC XY:
60
AN XY:
34398
show subpopulations
African (AFR)
AF:
0.000582
AC:
18
AN:
30940
American (AMR)
AF:
0.00188
AC:
20
AN:
10625
Ashkenazi Jewish (ASJ)
AF:
0.00341
AC:
9
AN:
2642
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3568
South Asian (SAS)
AF:
0.000370
AC:
1
AN:
2701
European-Finnish (FIN)
AF:
0.00378
AC:
23
AN:
6087
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
217
European-Non Finnish (NFE)
AF:
0.00372
AC:
198
AN:
53228
Other (OTH)
AF:
0.00391
AC:
6
AN:
1535
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
11
22
32
43
54
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00171
Hom.:
26
Bravo
AF:
0.00196
EpiCase
AF:
0.00360
EpiControl
AF:
0.00344

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
5
not provided (6)
-
-
3
not specified (3)
-
-
2
Lowe syndrome (2)
-
1
-
Developmental cataract (1)
-
-
1
Epilepsy (1)
-
1
-
Genetic developmental and epileptic encephalopathy (1)
-
-
1
Lowe syndrome;C1845167:Dent disease type 2 (1)
-
-
1
Nephrolithiasis/nephrocalcinosis (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.37
CADD
Benign
19
DANN
Benign
0.96
PhyloP100
5.3
Mutation Taster
=20/80
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
0.97
SpliceAI score (max)
0.61
Details are displayed if max score is > 0.2
DS_DL_spliceai
0.61
Position offset: -3

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61752971; hg19: chrX-128691930; API